课题基金 / 基金详情

ASPREE Completion Project

ASPREE Completion Project
ASPREE竣工项目
批准号:
nhmrc : GNT1127060
负责人:
A/Pr Robyn Woods
金额:
$479.67万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr Robyn Woods的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ASPREE is the largest clinical trial ever conducted in Australia and will determine whether daily low dose aspirin prevents disease in healthy older people. The study was well-funded initially but will require additional support to complete the vital final stage of data collection and analysis. This will enable the study to answer important questions about the benefits and risks of aspirin in this age group and its effect on disability free survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of aspirin in the prevention of colorectal cancer
  • 批准号:
    nhmrc : 1129811
  • 项目类别:
    Project Grants
  • 资助金额:
    $118.19万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Robyn Woods
  • 依托单位:
ASPREE Completion Project
  • 批准号:
    nhmrc : 1127060
  • 项目类别:
    Project Grants
  • 资助金额:
    $325.24万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Robyn Woods
  • 依托单位:
A Pilot Dementia Clinical Quality Registry to Improve Dementia Clinical Care
  • 批准号:
    nhmrc : 1140485
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $106.12万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Robyn Woods
  • 依托单位:
ASPREE-D; Aspirin in the prevention of depression in the elderly
  • 批准号:
    nhmrc : 1081901
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.13万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Robyn Woods
  • 依托单位:
海外基金